PACS on NYSE
PACS Group, Inc.
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with ENSIGN GROUP, INC or NATIONAL HEALTHCARE CORP, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
5.9%Operating margin3
3.6%Net margin3
29.4%Revenue growth, 20253
20.2%Return on equity3
0.26×Debt to equity3
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Other costs95¢$5.0B
- Income tax2¢$93.0M
- Profit4¢$191.5M
Out of $5.3B in revenue.3
Where each dollar of operating cash went, fiscal 2025
- Kept or used elsewhere100¢$404.2M
Out of $404.2M of cash from operations.3
Financial statements
Every line of the income statement in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Patient and resident service revenue | $5.3B | $4.1B | $3.1B |
| Additional funding | $0 | $0 | $375.0K |
| Other revenues | $1.0M | $3.1M | $1.0M |
| Total Revenue | $5.3B | $4.1B | $3.1B |
| Cost of services | $4.1B | $3.3B | $2.4B |
| Rent - cost of services | $378.9M | $285.0M | $216.7M |
| General and administrative expense | $415.1M | $343.8M | $213.7M |
| Depreciation and amortization | $55.7M | $40.8M | $25.6M |
| Total Operating Expenses | $5.0B | $4.0B | $2.9B |
| Operating income | $309.6M | $123.1M | $207.8M |
| Interest expense | -$28.4M | -$44.3M | -$49.9M |
| Gain on lease termination | $0 | $8.0M | $0 |
| Other income (expense), net | $3.2M | $14.8M | -$536.0K |
| Total Other Expense, Net | -$25.1M | -$21.5M | -$50.5M |
| Income before provision for income taxes | $284.4M | $101.6M | $157.3M |
| Provision for income taxes | $93.0M | $46.2M | $44.4M |
| Net Income | $191.5M | $55.3M | $112.9M |
| Net (loss) income attributable to noncontrolling interest | -$82.0K | -$416.0K | $8.0K |
| Net Income Attributable To PACS Group, Inc. | $191.5M | $55.8M | $112.9M |
| Basic (in us dollars per share) | $1.23 | $0.38 | $0.88 |
| Diluted (in us dollars per share) | $1.22 | $0.38 | $0.88 |
| Basic (in shares) | 156.2M shares | 146.7M shares | 128.7M shares |
| Diluted (in shares) | 156.7M shares | 148.6M shares | 128.7M shares |
Every line of the balance sheet in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $197.0M | $157.7M | $73.4M |
| Accounts receivable, net | $628.1M | $641.8M | |
| Other receivables | $74.0M | $74.7M | |
| Prepaid expenses and other current assets | $170.6M | $64.1M | |
| Total Current Assets | $1.1B | $938.3M | |
| Property and equipment, net | $1.2B | $990.6M | |
| Operating lease right-of-use assets | $3.0B | $3.0B | |
| Insurance subsidiary deposits and investments | $87.2M | $66.3M | |
| Escrow funds | $18.4M | $25.1M | |
| Goodwill and other indefinite-lived assets | $68.1M | $67.1M | |
| Other assets | $171.4M | $161.1M | |
| Total Assets | $5.6B | $5.2B | |
| Accounts payable | $192.2M | $175.1M | |
| Accrued payroll and benefits | $187.5M | $146.2M | |
| Current operating lease liabilities | $153.1M | $136.2M | |
| Current maturities of long-term debt | $4.5M | $14.9M | |
| Current portion of accrued self-insurance liabilities | $129.0M | $76.0M | |
| Current line of credit | $0 | $142.0M | |
| Refund liability | $181.1M | $145.8M | |
| Other accrued expenses | $154.0M | $142.3M | |
| Total Current Liabilities | $1.0B | $978.4M | |
| Long-term operating lease liabilities | $2.9B | $2.9B | |
| Line of credit | $100.0M | $0 | |
| Long-term debt, less current maturities, net of deferred financing fees | $244.8M | $251.0M | |
| Accrued self-insurance liabilities, less current portion | $192.6M | $165.0M | |
| Other liabilities | $152.9M | $197.1M | |
| Total Liabilities | $4.6B | $4.5B | |
| Common stock: $0.001 par value; 1,250,000,000 shares authorized; 156,615,144 shares issued and outstanding as of December 31, 2025, and $155,177,511 shares issued and outstanding as of December 31, 2024 | $157.0K | $155.0K | |
| Additional paid-in capital | $637.0M | $591.4M | |
| Retained earnings | $309.6M | $118.0M | |
| Total PACS Group, Inc. stockholders' equity | $946.8M | $709.6M | |
| Noncontrolling interest in subsidiary | $5.7M | $6.1M | |
| Total Equity | $952.4M | $715.7M | $101.7M |
| Total Liabilities and Equity | $5.6B | $5.2B | |
| Common stock, par value (in us dollars per share) | $0.00 | $0.00 | |
| Common stock, shares authorized (in shares) | 1.2B shares | 1.2B shares | |
| Common stock, shares issued (in shares) | 156.6M shares | 155.2M shares | |
| Common stock, shares outstanding (in shares) | 156.6M shares | 155.2M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | $191.5M | $55.3M | $112.9M |
| Depreciation and amortization | $55.7M | $40.8M | $25.6M |
| Amortization and write-off of deferred financing fees | $3.1M | $3.1M | $6.1M |
| Stock-based compensation | $54.1M | $115.5M | $0 |
| Loss on investment in partnership | $773.0K | $4.6M | $391.0K |
| Gain on insurance subsidiary deposits and investments | -$4.9M | -$1.3M | $0 |
| Deferred taxes | -$17.7M | -$44.5M | -$9.9M |
| Noncash lease expense | $48.5M | $34.6M | $22.7M |
| Other noncash operating activities | $573.0K | $843.0K | $581.0K |
| Accounts receivable, net | $13.6M | -$94.0M | -$176.9M |
| Other receivables | $781.0K | -$22.5M | -$3.1M |
| Prepaid expenses and other current assets | -$69.5M | -$17.2M | -$18.8M |
| Other assets | -$2.7M | -$13.3M | -$3.3M |
| Escrow funds | $6.7M | -$9.5M | $568.0K |
| Operating lease liabilities | -$1.2M | -$20.8M | -$2.0M |
| Accounts payable | $14.9M | $33.4M | $33.4M |
| Accrued payroll and benefits | $41.0M | $52.0M | $6.3M |
| Accrued self-insurance liabilities | $80.6M | $67.2M | $35.6M |
| Refund liability | $35.3M | $145.8M | $0 |
| Other accrued expenses | $13.2M | $73.2M | -$55.5M |
| Other liabilities | -$60.1M | -$36.2M | $89.1M |
| NET CASH PROVIDED BY OPERATING ACTIVITIES | $404.2M | $367.3M | $63.7M |
| Investment in partnerships | $0 | -$32.9M | -$2.6M |
| Non-operating distributions from investment in partnership | $5.6M | $3.5M | $1.9M |
| Purchase of available-for-sale securities | -$21.2M | -$90.9M | $0 |
| Sale of available-for-sale securities | $0 | $25.9M | $0 |
| Acquisition of facilities | -$143.8M | -$283.3M | -$127.0M |
| Purchase of property and equipment | -$105.4M | -$66.5M | -$45.8M |
| Proceeds from the sale of assets | $750.0K | $1.5M | $750.0K |
| NET CASH USED IN INVESTING ACTIVITIES | -$264.0M | -$442.7M | -$172.8M |
| Borrowing on lines of credit, net of deferred financing fees | $0 | $676.0M | $855.7M |
| Payments on lines of credit | -$42.0M | -$1.1B | -$498.0M |
| Borrowings of long-term debt, net of deferred financing fees | $0 | $72.3M | $411.3M |
| Payments on long-term debt | -$18.2M | -$19.5M | -$559.6M |
| Noncontrolling interest distribution | -$377.0K | $0 | $0 |
| Contributions from noncontrolling interest | $0 | $502.0K | $587.0K |
| Dividends on common stock | $0 | -$33.7M | -$80.4M |
| Proceeds from initial public offering, net of issuance costs | $0 | $414.2M | $0 |
| Proceeds from common stock offering, net of issuance costs | $0 | $95.3M | $0 |
| Taxes paid related to net share settlement of equity awards | -$8.4M | -$33.6M | $0 |
| NET CASH (USED IN)/PROVIDED BY FINANCING ACTIVITIES | -$69.0M | $117.5M | $129.6M |
| Net change in cash | $71.2M | $42.1M | $20.5M |
| Interest | $40.5M | $48.2M | $50.6M |
| Income taxes | $84.0M | $107.8M | $60.0M |
| Accrued capital expenditures | $6.0M | $3.7M | $3.0M |
| Assets acquired in operation expansions in exchange for notes payable | $0 | $0 | $2.1M |
| Assets acquired in operation expansions through settlement of notes receivable | $0 | $500.0K | $0 |
| Contributions from noncontrolling interest through relief of notes payable | $0 | $451.0K | $0 |
Recent filings
- Oct 14, 2026144
- Oct 7, 20264
- Oct 5, 20264
- Sep 25, 20263
- Sep 21, 20268-K
- Sep 17, 20264
- Sep 15, 2026144
- Sep 15, 20264
- Sep 15, 2026144
- Sep 14, 20264
- Sep 10, 2026144
- Sep 9, 20264
- Sep 3, 20264
- Sep 1, 2026144
- Aug 27, 20264
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6